Govt Inaction Lets Firm Sell Human Milk Using HC Stay
Bengaluru: Nearly two years after its licence was cancelled, Neolacta, a Bengaluru-based company, continues to process and sell human milk despite this being not permitted under the Food Safety and…
Gujarat FDCA Launches Pilot Project To Combat AMR
Mumbai: The Gujarat Food and Drug Control Administration (FDCA) has launched a pilot project to combat antimicrobial resistance (AMR), a growing global health threat. This initiative aims to empower and equip…
Illegal Ozempic Shipments Are Coming Into US, Says CBP
Washington: Customs and Border Protection (CBP in the US says it is regularly intercepting shipments of counterfeit and otherwise illegal versions of Novo Nordisk’s diabetes therapy Ozempic, as consumers in…
Telangana Govt To Crack Down On Fake Medicine Manufacturers
Hyderabad: Health Minister Damodar Rajanarsimha said on Monday that the government had taken steps to crack down on the fake medicine manufacturers with an iron fist. On Monday, the Health Minister…
Akums Launches Novel Formulations For Patients With Gastrointestinal Disorders
New Delhi: Akums Drugs & Pharmaceuticals Ltd on Monday announced that it has launched Rabeprazole + Levosulpiride SR Capsules. Approved by the Drug Controller General of India (DCGI), the company claims…
SII Sees Demand Doubling In Five Years
Pune: Serum Institute of India Pvt. is expanding its production capacity as it expects sales of life-saving vaccines, including those for malaria and cervical cancer, to double in the next five…
Lupin Recalls 51k Bottles Of Generic Antibiotic Drug In US
New Delhi: Drug firm Lupin is recalling over 51,000 bottles of a generic antibiotic medication in the U.S. market due to a “defective container”, according to the American health regulator.…
NDLEA Intercepts Another Shipment Of Codeine From India
Lagos: The recent interception of 175,000 bottles of opioids imported from India by the National Drug Law Enforcement Agency (NDLEA) comes shortly after the seizure of a similar shipment at…
CBI To Probe Ex-Assistant Drugs Controller Misconduct: High Court
New Delhi: In a significant development, the High Court of Punjab and Haryana has directed the Central Bureau of Investigation (CBI) to take over the investigation of a case involving…
FoPE Raises Concerns Over New Schedule M’s Impact On Cosmetic Manufacturing
New Delhi: The pharmaceutical industry has raised concerns regarding the government’s newly notified schedule M that proposes a blanket ban on manufacture of any other article or product apart from drugs…
